The Latest Cardiac and Vascular News
Kevil brings global scientific expertise to advance JanOne’s drug development portfolio and advise on upcoming Phase 2b clinical trials for PAD LAS VEGAS, Jan. 16, 2020 /PRNewswire/ — JanOne Inc. (NASDAQ:JAN) appoints Christopher Kevil, Ph.D., a pioneer in nitrite based PAD treatment, to lead its scientific advisory board. In this role, Dr. Kevil will […]
Early Results from First 24 Patients Show Excellent Safety Profile and Technical Performance, with Significant Debris Capture and Removal in All Patients SANTA CRUZ, Calif.–(BUSINESS WIRE)–Emboline™, Inc., developer of total embolic protection technology for transcatheter aortic valve replacement (TAVR), today announced completion of enrollment in its SafePass™ 2 clinical study […]
Dr. Milton Leon is opening the San Angelo Cardiovascular Center of Excellence to bring quality care, cost savings, and convenience to the area SAN ANGELO, Texas, Jan. 13, 2020 /PRNewswire/ — San Angelo is getting its first outpatient catheterization lab, bringing a new level of convenience, cost savings, and state-of-the art care to […]
DETOUR Procedure Designed to Move Treatment from Inpatient to Outpatient Setting MILPITAS, Calif.–(BUSINESS WIRE)–Silicon Valley-based medical device company PQ Bypass announced today the 100th patient in the DETOUR2 Clinical Trial, which evaluates the safety and effectiveness of the minimally invasive DETOUR procedure for percutaneous femoropopliteal bypass. The case was performed […]
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Reflow Medical announces that the Temporary Spur Stent System, a novel retrievable stent technology intended for the treatment of below-the-knee (BTK) peripheral artery disease, has been designated for the Breakthrough Devices Program by the U.S. Food and Drug Administration (FDA). The Breakthrough Devices Program is designed to […]
SALT LAKE CITY–(BUSINESS WIRE)–Alucent Biomedical Inc. has received U.S. Food and Drug Administration approval to proceed with a Phase 1 clinical trial to evaluate the safety and efficacy of its revolutionary Natural Vascular Scaffolding (NVS) technology. The therapy is designed to treat peripheral artery disease (PAD) of the lower extremities, a […]
ALAMEDA, Calif.–(BUSINESS WIRE)–Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today announced U.S. Food and Drug Administration 510(k) clearance for expanded indication of the Indigo® Aspiration System. As part of the Indigo Aspiration System, the Indigo Aspiration Catheters and Separators are indicated for the removal of fresh, […]
HINGHAM, Mass., Jan. 08, 2020 (GLOBE NEWSWIRE) — Microbot Medical Inc. (Nasdaq: MBOT) has received an official communication from the European Patent Office (EPO) regarding its intention to grant European Patent Application No. 11795301, covering the Company’s Self-Cleaning Shunt (SCS™). Globally, the Company now has 36 patents issued/allowed and 16 […]
TEL AVIV, Israel, Jan. 6, 2020 /PRNewswire/ — Vascular Graft Solutions (VGS) announces on the acquisition of several patent families from NEOGRAFT Technologies Inc. which include patents that were previously developed and owned by Kipsbay Medical Inc, a pioneer in the field of venous external stenting and vascular engineering. The patents portfolio, which includes […]
Latest accomplishment reached by Silicon Valley med-tech company currently enrolling two IDE studies MILPITAS, Calif.–(BUSINESS WIRE)–PQ Bypass Inc, a medical device company bringing new advancements to the treatment of peripheral artery disease (PAD), announced today that it has received approval for coverage from the Centers for Medicare and Medicaid Services […]
